Abstract
Congenital urinary tract obstruction is an important cause of renal disease in children. Early animal studies have shown a relationship between the timing of obstruction and the different pathological entities that collectively comprise renal maldevelopment. A multitude of molecular factors through both in-vivo and in-vitro studies have been identified that are involved in apoptosis and/or interstitial fibrosis as a result of urinary tract obstruction. These molecular factors have been found to work in parallel and also occasionally divergent pathways. Apoptosis is a prominent feature of early in-utero urinary tract obstruction and a major factor in the loss of renal mass and renal dysfunction. Furthermore, there is an increasing body of evidence to suggest that apoptosis is an inciting event in the development of progressive interstitial fibrosis which further contributes to renal demise. Clearly, a better understanding of the mechanisms of apoptosis and the subsequent development of targeted therapies directed against apoptosis may prove beneficial in the prevention of renal dysfunction associated with urinary tract obstruction.
Keywords: Apoptosis, interstitial fibrosis, obstruction, nephropathy, cystic dysplasia, hydronephrosis, renal tubular cells, Osteopontin, Angiotensin II, urinary tract
Current Pediatric Reviews
Title: Apoptosis in Obstructive Nephropathy
Volume: 7 Issue: 4
Author(s): Ethan I. Franke and Kirstan K. Meldrum
Affiliation:
Keywords: Apoptosis, interstitial fibrosis, obstruction, nephropathy, cystic dysplasia, hydronephrosis, renal tubular cells, Osteopontin, Angiotensin II, urinary tract
Abstract: Congenital urinary tract obstruction is an important cause of renal disease in children. Early animal studies have shown a relationship between the timing of obstruction and the different pathological entities that collectively comprise renal maldevelopment. A multitude of molecular factors through both in-vivo and in-vitro studies have been identified that are involved in apoptosis and/or interstitial fibrosis as a result of urinary tract obstruction. These molecular factors have been found to work in parallel and also occasionally divergent pathways. Apoptosis is a prominent feature of early in-utero urinary tract obstruction and a major factor in the loss of renal mass and renal dysfunction. Furthermore, there is an increasing body of evidence to suggest that apoptosis is an inciting event in the development of progressive interstitial fibrosis which further contributes to renal demise. Clearly, a better understanding of the mechanisms of apoptosis and the subsequent development of targeted therapies directed against apoptosis may prove beneficial in the prevention of renal dysfunction associated with urinary tract obstruction.
Export Options
About this article
Cite this article as:
I. Franke Ethan and K. Meldrum Kirstan, Apoptosis in Obstructive Nephropathy, Current Pediatric Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339611796892346
DOI https://dx.doi.org/10.2174/157339611796892346 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER
Anti-Cancer Agents in Medicinal Chemistry Celecoxib A Selective COX-2 Inhibitor Mitigates Fibrosis but not Pneumonitis Following Lung Irradiation: A Histopathological Study
Current Drug Therapy The Acidocalcisome as a Target for Chemotherapeutic Agents in Protozoan Parasites
Current Pharmaceutical Design Clinical Application of Human Oocyte Cryopreservation
Reviews on Recent Clinical Trials Editorial (Thematic Issue: Mitochondrial Biogenesis: Pharmacological Approaches)
Current Pharmaceutical Design Antiviral Activity of Substituted Salicylanilides - A Review
Mini-Reviews in Medicinal Chemistry Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors
Current Alzheimer Research Monitoring the Switch: The Warburg Effect and Targeted Proteomic Analysis of Cancer Metabolism
Current Proteomics Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1
Current Molecular Pharmacology Therapeutic Drug Monitoring of Busulfan in Transplantation
Current Pharmaceutical Design TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry Degradation of Androgen Receptor through Small Molecules for Prostate Cancer
Current Cancer Drug Targets A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved
Current Signal Transduction Therapy NMR-based Metabolite Profiling of Pancreatic Cancer
Current Metabolomics Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued)